New tool could support “faster diagnosis” of Parkinson’s disease psychosis

News

Author: Saskia MairPublished: 24 September 2020

Prep: Cook: Serves:

Shot of a doctor showing a patient some information on a digital tablet

A new screening tool has been developed to support the early diagnosis of Parkinson’s disease psychosis – a symptom of the condition that is often misdiagnosed.

Created by Canadian senior care software company, PointClickCare and membership organisation, the American Society of Consultant Pharmacists (ASCP), the platform asks questions on topics like hallucinations and delusions. Healthcare workers can then review the responses and decide to collect more information and create a care plan. Data collected through the tool will also be used to help scientific research in healthcare organisations.

Bill Stuart, clinical product strategist at PointClickCare said: “Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson’s psychosis.”

Chad Worz, chief executive of ASCP, added: “We are excited to have another tool for care teams to facilitate a more standardised care process for Parkinson’s disease and we are excited for the role that pharmacists play in this process.”

Last Month

Next Month

Go Back

Share this story

Comments

Advances

CES 2017: 5 innovative gadgets for people with Parkinson’s

We round up the latest hi-tech health aids for people with Parkinson’s

New patient-centred study will harvest data via smartphones

New iPhone app could gather data of 20,000 patients

One symbol, one voice: ramping up the voltage on World Parkinson’s Day

Take part in a global Parkinson’s disease initiative

Study suggests why neurons die in Parkinson’s disease

Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

News

Author: Saskia MairPublished: 24 September 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

CES 2017: 5 innovative gadgets for people with Parkinson’s

Advances

New patient-centred study will harvest data via smartphones

Global update

One symbol, one voice: ramping up the voltage on World Parkinson’s Day

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

News

Author: Saskia MairPublished: 24 September 2020

Last Month

Next Month

Share this story

Comments

Related articles

Advances

CES 2017: 5 innovative gadgets for people with Parkinson’s

Advances

New patient-centred study will harvest data via smartphones

Global update

One symbol, one voice: ramping up the voltage on World Parkinson’s Day

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Sign in